| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7K | -92.8% |
| SG&A Expense | $224K | -18.6% |
| Pre-tax Income | -$327.4M | — |
| Income Tax | $0 | — |
| Net Income | -$327K | +44.6% |
| EPS (Basic) | $0.00 | +100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12K | -92.5% |
| Total Assets | $40K | -78.5% |
| Current Liabilities | $449K | +64.0% |
| Stockholders' Equity | -$409K | -356.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$147K | +72.5% |